Inhibikase Therapeutics Inc (IKT)
1.83
-0.06
(-3.17%)
USD |
NASDAQ |
May 22, 16:00
1.83
0.00 (0.00%)
After-Hours: 20:00
Inhibikase Therapeutics 1 Year Total Returns (Daily): -50.78% for May 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 21, 2024 | -50.78% |
May 20, 2024 | -51.56% |
May 17, 2024 | -56.31% |
May 16, 2024 | -54.95% |
May 15, 2024 | -49.75% |
May 14, 2024 | -58.11% |
May 13, 2024 | -63.01% |
May 10, 2024 | -64.19% |
May 09, 2024 | -62.95% |
May 08, 2024 | -62.96% |
May 07, 2024 | -67.56% |
May 06, 2024 | -66.79% |
May 03, 2024 | -56.38% |
May 02, 2024 | -58.95% |
May 01, 2024 | -59.10% |
April 30, 2024 | -56.16% |
April 29, 2024 | -52.58% |
April 26, 2024 | -48.17% |
April 25, 2024 | -46.97% |
April 24, 2024 | -46.26% |
April 23, 2024 | -57.51% |
April 22, 2024 | -63.16% |
April 19, 2024 | -40.97% |
April 18, 2024 | -39.54% |
April 17, 2024 | -38.85% |
Date | Value |
---|---|
April 16, 2024 | -38.53% |
April 15, 2024 | -36.53% |
April 12, 2024 | -34.93% |
April 11, 2024 | -32.26% |
April 10, 2024 | -33.03% |
April 09, 2024 | -36.35% |
April 08, 2024 | -33.95% |
April 05, 2024 | -40.88% |
April 04, 2024 | -40.85% |
April 03, 2024 | -42.01% |
April 02, 2024 | -45.51% |
April 01, 2024 | -45.26% |
March 28, 2024 | -50.57% |
March 27, 2024 | -49.78% |
March 26, 2024 | -46.99% |
March 25, 2024 | -48.84% |
March 22, 2024 | -43.56% |
March 21, 2024 | -38.82% |
March 20, 2024 | -43.06% |
March 19, 2024 | -50.51% |
March 18, 2024 | -48.46% |
March 15, 2024 | -49.76% |
March 14, 2024 | -47.79% |
March 13, 2024 | -50.13% |
March 12, 2024 | -43.00% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-87.20%
Minimum
May 12 2022
1.59%
Maximum
May 19 2023
-59.70%
Average
-59.98%
Median
Aug 24 2023
1 Year Total Returns (Daily) Benchmarks
Bio-Path Holdings Inc | -93.46% |
Hepion Pharmaceuticals Inc | -86.81% |
ProKidney Corp | -59.78% |
NKGen Biotech Inc | -- |
Telomir Pharmaceuticals Inc | -- |